Analysts’ Viewpoint on Saudi Arabia Veterinary Therapeutics Market Scenario
The rise in prevalence of chronic conditions in pets is expected to drive the Saudi Arabia veterinary therapeutics market. The Saudi Arabia veterinary therapeutics market is majorly driven by increasing innovations and research & development activities in veterinary medicines. Players are continuously focusing on drug development by considering the overall efficacy of their products. Some of the factors responsible for the rapid expansion of the market are rising awareness among consumers, cost-efficiency of products, easy availability, etc. The policies implemented by the Saudi Arabia Government to support the agricultural sector are driving the global market.
In the recent years, there has been an increase in demand for high quality proteins in the veterinary drugs. Increase in demand animal proteins, awareness about the nutrition, and food safety are some of the factors responsible for the improvement in livestock medicines. These factors are anticipated to boost the demand for high quality proteins. The growing administration of veterinary drugs, antibiotics, and amino acids through oral route, along with feed additives is rapidly adopted in Saudi Arabia. Veterinary medications field is continuously evolving, as it plays an important role in the medical field. The rising support from the Saudi Arabia Government to promote agricultural acclivities is encouraging manufacturers to develop technologically advanced and highly-efficient products.
To know the scope of our report Get a Sample on Veterinary Therapeutics Market
The veterinary therapeutics market players in Saudi Arabia are expected to witness incremental opportunities to pave their way in the market. Various policies offered by the Saudi Arabia Government to encourage private players in the veterinary therapeutics market are expected to boost the market in the upcoming years. Services such as technical support, long-term, interest-free loans, incentives, free seeds & fertilizers, low-cost water, fuel, and electricity are provided by the Saudi Arabia Government to promote the agriculture industry. In addition, duty-free imports of raw materials & machineries are given to farmers to increase the production. Subsidies are being provided by the Government to export corn, as corn is widely used in the animal feed in poultry. The private sector has played a major role in the development of the agriculture sector in the country.
Get a glimpse of the in-depth analysis through our Report Brochure
Increase in the number of veterinary hospitals and clinics in Saudi Arabia is expected to drive the veterinary therapeutics market during the forecast period. Improvements in services offered by such hospitals and clinics are projected to propel the growth of the market. The Saudi Arabia veterinary therapeutics market is significantly driven by rise in pet ownership in the country. This has increased the demand for veterinary clinics in the region. In addition, the rising number of veterinary pharmacies is also expected to boost the market.
In addition, rising sales of over-the-counter veterinary drugs and other pharmaceutical products is anticipated to create lucrative opportunities for market players. Companies operating in the Saudi Arabia veterinary therapeutics market are increasing day-by-day. These players are more likely to gain potential revenue benefits during the forecast period.
Expanding operations in future? To get the perfect launch ask for a custom report
The growing demand for products such as veterinary drugs, vaccines, and medicated feed additives in Saudi Arabia is expected to drive the global market. Rise in demand for anti infective, anti-inflammatory drugs, and parasiticides is creating opportunities for the market players. These drugs are used to keep livestock disease-free. There is tremendous rise in the adoption of companion animals. The ownership of companion animals is expected to rise in the near future, which, in turn, is likely to drive the veterinary therapeutics market in Saudi Arabia. Increasing regulations on the usage of antibiotics in Saudi Arabia hampers the expansion of the market. Vaccines are also high in demand due to rising prevalence of zoonotic diseases. Market players in the Saudi Arabia veterinary therapeutics market are accelerating their services and unlocking revenue opportunities to gain competitive benefits.
Attribute |
Detail |
Market Size Value in 2020 |
US$ 452.7 Mn |
Market Forecast Value in 2031 |
US$ 805 Mn |
Growth Rate (CAGR) |
5.5% |
Forecast Period |
2021–2031 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes cross segment analysis at country level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Country Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
Saudi Arabia Veterinary Therapeutics Market – Segmentation
TMR’s study on the veterinary therapeutics market in Saudi Arabia includes information divided into five segments: product, animal type, route of administration, distribution channel, and country. Changing industry trends and other market dynamics associated with these segments of the veterinary therapeutics market in Saudi Arabia are discussed in detail.
Product |
|
Animal Type |
|
Route of Administration |
|
Distribution Channel |
|
Country |
|
Saudi arabia veterinary therapeutics market is expected to reach the value of US$ 805 Mn by the end of 2031
Saudi arabia veterinary therapeutics market to expand at a CAGR of 5.5% from 2021 to 2031
Veterinary therapeutics market is driven by rise in number of veterinary hospitals & clinics in saudi arabia
The livestock animals segment dominated the saudi arabia veterinary therapeutics market
Key players in the saudi arabia veterinary therapeutics market include Boehringer Ingelheim International GmbH, Ceva Santé Animale, Dechra Pharmaceuticals plc, Elanco, Al-Takamul Agriculture Co.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Saudi Arabia Veterinary Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Disease Prevalence and Incidence rate
5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Drugs
6.3.1.1. Anti-infective
6.3.1.2. Anti-inflammatory
6.3.1.3. Parasiticides
6.3.1.4. Others
6.3.2. Vaccines
6.3.2.1. Inactivated Vaccines
6.3.2.2. Live Attenuated Vaccines
6.3.2.3. Recombinant Vaccines
6.3.2.4. Others
6.3.3. Medicated Feed Additives
6.3.3.1. Amino Acids
6.3.3.2. Antibiotics
6.3.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Veterinary Hospitals & Clinics
7.3.2. Pharmacies & Drug Stores
7.3.3. Others
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2017–2031
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Others
8.4. Market Attractiveness Analysis, by Route of Administration
9. Saudi Arabia Veterinary Therapeutics Market Analysis and Forecast, by Animal Type
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Animal Type, 2017–2031
9.3.1. Companion Animals
9.3.2. Livestock & Others
9.4. Market Attractiveness Analysis, by Animal Type
10. Competition Landscape
10.1. Market Player – Competition Matrix (by tier and size of companies)
10.2. Market Share Analysis, by Company, 2020
10.3. Company Profiles
10.3.1. Boehringer Ingelheim International GmbH
10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.1.2. Company Financials
10.3.1.3. Growth Strategies
10.3.1.4. SWOT Analysis
10.3.2. Ceva Santé Animale
10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.2.2. Company Financials
10.3.2.3. Growth Strategies
10.3.2.4. SWOT Analysis
10.3.3. Dechra Pharmaceuticals plc
10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.3.2. Company Financials
10.3.3.3. Growth Strategies
10.3.3.4. SWOT Analysis
10.3.4. Elanco
10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.4.2. Company Financials
10.3.4.3. Growth Strategies
10.3.4.4. SWOT Analysis
10.3.5. Al-Takamul Agriculture Co.
10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.5.2. Company Financials
10.3.5.3. Growth Strategies
10.3.5.4. SWOT Analysis
10.3.6. Virbac
10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.6.2. Company Financials
10.3.6.3. Growth Strategies
10.3.6.4. SWOT Analysis
10.3.7. Vetoquinol S.A.
10.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.7.2. Company Financials
10.3.7.3. Growth Strategies
10.3.7.4. SWOT Analysis
10.3.8. Zoetis Health
10.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.8.2. Company Financials
10.3.8.3. Growth Strategies
10.3.8.4. SWOT Analysis
10.3.9. Saudi Pharmaceutical Industries (SPI)
10.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.9.2. Company Financials
10.3.9.3. Growth Strategies
10.3.9.4. SWOT Analysis
List of Tables
Table 01: Saudi Arabia Veterinary Therapeutics Market, by Product, 2017–2031
Table 02: Saudi Arabia Veterinary Therapeutics Market, by Drugs, 2017–2031
Table 03: Saudi Arabia Veterinary Therapeutics Market, by Vaccines 2017–2031
Table 04: Saudi Arabia Veterinary Therapeutics Market, by Medicated Feed Additives, 2017–2031
Table 05: Saudi Arabia Veterinary Therapeutics Market, by Distribution Channel, 2017–2031
Table 06: Saudi Arabia Veterinary Therapeutics Market, by Route of Administration, 2017–2031
Table 07: Saudi Arabia Veterinary Therapeutics Market, by Animal Type, 2017–2031
List of Figures
Figure 01: Saudi Arabia Veterinary Therapeutics Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Saudi Arabia Veterinary Therapeutics Market Value Share, by Product, 2020
Figure 03: Saudi Arabia Veterinary Therapeutics Market Value Share, by Distribution Channel, 2020
Figure 04: Saudi Arabia Veterinary Therapeutics Market Value Share, by Route of Administration, 2020
Figure 05: Saudi Arabia Veterinary Therapeutics Market Value Share, by Animal Type, 2020
Figure 06: Saudi Arabia Veterinary Therapeutics Market, by Product, 2020 and 2031
Figure 07: Saudi Arabia Veterinary Therapeutics Market, by Product, 2021–2031
Figure 08: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Drugs, 2017–2031
Figure 09: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Vaccines, 2017–2031
Figure 10: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Medicated Feed Additives, 2017–2031
Figure 11: Saudi Arabia Veterinary Therapeutics Market, by Distribution Channel, 2020 and 2031
Figure 12: Saudi Arabia Veterinary Therapeutics Market, by Distribution Channel, 2021–2031
Figure 13: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Veterinary Hospitals & Clinics, 2017–2031
Figure 14: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Pharmacies & Drug Stores, 2017–2031
Figure 15: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Others, 2017–2031
Figure 16: Saudi Arabia Veterinary Therapeutics Market, by Route of Administration, 2020 and 2031
Figure 17: Saudi Arabia Veterinary Therapeutics Market, by Route of Administration, 2021–2031
Figure 18: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Oral, 2017–2031
Figure 19: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Parenteral, 2017–2031
Figure 20: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Others, 2017–2031
Figure 21: Saudi Arabia Veterinary Therapeutics Market, by Animal Type, 2020 and 2031
Figure 22: Saudi Arabia Veterinary Therapeutics Market, by Animal Type, 2021–2031
Figure 23: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Companion Animals, 2017–2031
Figure 24: Saudi Arabia Veterinary Therapeutics Market (US$ Mn), by Livestock Animals, 2017–2031